All Title Author
Keywords Abstract


Pediatric Influenza-Associated Deaths in New York State: Death Certificate Coding and Comparison to Laboratory-Confirmed Deaths

DOI: 10.1155/2012/397890

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction. Surveillance for laboratory-confirmed influenza-associated deaths in children is used to monitor the severity of influenza at the population level and to inform influenza prevention and control policies. The goal of this study was to better estimate pediatric influenza mortality in New York state (NYS). Methods. Death certificate data were requested for all passively reported deaths and any pneumonia and influenza (P&I) coded pediatric deaths occurring between October 2004 and April 2010, excluding New York City (NYC) residents. A matching algorithm and capture-recapture analysis were used to estimate the total number of influenza-associated deaths among NYS children. Results. Thirty-four laboratory-confirmed influenza-associated pediatric deaths were reported and 67 death certificates had a P&I coded death; 16 deaths matched. No laboratory-confirmed influenza-associated death had a pneumonia code and no pneumonia coded deaths had laboratory evidence of influenza infection in their medical record. The capture-recapture analysis estimated between 38 and 126 influenza-associated pediatric deaths occurred in NYS during the study period. Conclusion. Passive surveillance for influenza-associated deaths continues to be the gold standard methodology for characterizing influenza mortality in children. Review of death certificates can complement but not replace passive reporting, by providing better estimates and detecting any missed laboratory-confirmed deaths. 1. Introduction It has long been recognized that influenza is associated with substantial mortality during both epidemics and pandemics. Death due to influenza virus infection can result from a variety of causes, such as pneumonia or exacerbations of existing cardiopulmonary or other chronic conditions. Influenza-associated death among children in particular is rare, but when it occurs, it is often rapidly fatal and may affect children with no predisposing risk factor [1, 2]. Bacterial coinfections, especially methicillin-resistant Staphylococcus aureus (MRSA), are also increasingly being documented among influenza-associated pediatric deaths [1]. These were important factors in the Advisory Committee on Immunization Practices (ACIP) expanding influenza vaccine recommendations in 2008 to include all children aged 6 months through 18 years [3] when in years prior influenza vaccine was only recommended for children less than five years of age. Due to increased reports of deaths in children associated with influenza in the 2003-04 season [4, 5], in October 2004 laboratory-confirmed

References

[1]  L. Finelli, A. Fiore, R. Dhara et al., “Influenza-associated pediatric mortality in the united states: increase of Staphylococcus aureus coinfection,” Pediatrics, vol. 122, no. 4, pp. 805–811, 2008.
[2]  B. F. Johnson, L. E. Wilson, J. Ellis, et al., “Fatal cases of influenza a in childhood,” PLoS One, vol. 30, no. 4, article e7671, 2009.
[3]  Centers for Disease Control and Prevention, “Prevention and control of influenza: recommendations of the advisory committee on immunization practices,” Morbidity and Mortalilty Weekly Report, vol. 57, no. RR-7, pp. 1–60, 2008.
[4]  N. Bhat, J. G. Wright, K. R. Broder et al., “Influenza-associated deaths among children in the United States, 2003-2004,” The New England Journal of Medicine, vol. 353, no. 24, pp. 2559–2567, 2005.
[5]  Centers for Disease Control and Prevention, “Update: influenza-associated deaths reported among children aged years—United States, 2003-04 influenza season,” Morbidity and Mortalilty Weekly Report, vol. 52, pp. 1286–1288, 2004.
[6]  C. M. Cox, L. Blanton, R. Dhara, L. Brammer, and L. Finelli, “2009 pandemic influenza a (H1N1) deaths among children-United States, 2009-2010,” Clinical Infectious Diseases, vol. 52, supplement 1, pp. S69–S74, 2011.
[7]  F. S. Dawood, A. Fiore, L. Kamimoto et al., “Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003–2008,” Pediatric Infectious Disease Journal, vol. 29, no. 7, pp. 585–590, 2010.
[8]  W. W. Thompson, E. Weintraub, P. Dhankhar et al., “Estimates of US influenza-associated deaths made using four different methods,” Influenza and other Respiratory Viruses, vol. 3, no. 1, pp. 37–49, 2009.
[9]  W. W. Thompson, M. R. Moore, E. Weintraub et al., “Estimating influenza-associated deaths in the United States,” American Journal of Public Health, vol. 99, no. 2, pp. S225–S230, 2009.
[10]  Centers for Disease Control and Prevention, “122 cities mortality reporting system,” http://www.cdc.gov/flu/weekly/overview.htm#Mortality.
[11]  C. G. Grijalva, G. A. Weinberg, N. M. Bennett et al., “Estimating the undetected burden of influenza hospitalizations in children,” Epidemiology and Infection, vol. 135, no. 6, pp. 951–958, 2007.
[12]  A. M. Hetzel, History and Organization of the Vital Statistics System, National Center for Health Statistics, Hyattsville, Md, USA, 1997.
[13]  A. Chao, P. K. Tsay, S. H. Lin, W. Y. Shau, and D. Y. Chao, “The applications of capture-recapture models to epidemiological data,” Statistics in Medicine, vol. 20, no. 20, pp. 3123–3157, 2001.
[14]  Centers for Disease Control and Prevention, “Swine influenza A, (H1N1) infection in two children—Southern California, March-April 2009,” Morbidity and Mortalilty Weekly Report, vol. 58, pp. 400–402, 2009.
[15]  M. R. Mueller, P. J. Smith, J. P. Baumbach et al., “Influenza testing and antiviral prescribing practices among emergency department clinicians in 9 states during the 2006 to 2007 influenza season,” Annals of Emergency Medicine, vol. 55, no. 1, pp. 32–39, 2010.
[16]  W. W. Thompson, D. K. Shay, E. Weintraub et al., “Mortality associated with influenza and respiratory syncytial virus in the United States,” Journal of the American Medical Association, vol. 289, no. 2, pp. 179–186, 2003.
[17]  J. Dushoff, J. B. Plotkin, C. Viboud, D. J. D. Earn, and L. Simonsen, “Mortality due to influenza in the United States—an annualized regression approach using multiple-cause mortality data,” American Journal of Epidemiology, vol. 163, no. 2, pp. 181–187, 2006.
[18]  I. M. Foppa and M. M. Hossain, “Revised estimates of influenza-associated excess mortality, united states, 1995 through 2005,” Emerging Themes in Epidemiology, vol. 5, article 26, 2008.
[19]  G. L. Armstrong, L. Brammer, and L. Finelli, “Timely assessment of the severity of the 2009 H1N1 influenza pandemic,” Clinical Infectious Diseases, vol. 52, supplement 1, pp. S83–S89, 2011.
[20]  A. Noymer, “Influenza analysis should include pneumonia,” American Journal of Public Health, vol. 98, no. 11, pp. 1927–1928, 2008.
[21]  W. W. Thompson, L. Comanor, and D. K. Shay, “Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease,” Journal of Infectious Diseases, vol. 194, no. 2, pp. S82–S91, 2006.
[22]  M. B. Rothberg and S. D. Haessler, “Complications of seasonal and pandemic influenza,” Critical Care Medicine, vol. 38, no. 4, pp. e91–e97, 2010.
[23]  E. Lahti, V. Peltola, R. Virkki, and O. Ruuskanen, “Influenza pneumonia,” Pediatric Infectious Disease Journal, vol. 25, no. 2, pp. 160–164, 2006.
[24]  M. B. Rothberg, S. D. Haessler, and R. B. Brown, “Complications of viral influenza,” American Journal of Medicine, vol. 121, no. 4, pp. 258–264, 2008.
[25]  C. M. Cox, L. Blanton, R. Dhara, L. Brammer, and L. Finelli, “2009 pandemic influenza a (H1N1) deaths among children-United States, 2009-2010,” Clinical Infectious Diseases, vol. 52, supplement 1, pp. S69–S74, 2011.
[26]  Centers for Disease Control and Prevention, “Influenza-associated pediatric deaths—United States, September 2010-August 2011,” Morbidity and Mortalilty Weekly Report, vol. 60, no. 36, pp. 1233–1238, 2011.

Full-Text

comments powered by Disqus